Value of information literature analysis: A review of applications in health risk management

Medical Decision Making

Volumn 24, Issue 3, 2004, Pages 287-298

  Yokota, Fumie ^a   Thompson, Kimberly M ^a  

^a NONE

Author keywords

Bayesian decision theory; Data worth; Health risk management; Preposterior analysis; Value of information

Indexed keywords

BAYES THEOREM; CROSS FERTILIZATION; DECISION MAKING; EVOLUTION; HEALTH HAZARD; MANAGEMENT; MEDICAL INFORMATION; METHODOLOGY; PEER REVIEW; PROBLEM SOLVING; REVIEW; RISK MANAGEMENT; STANDARDIZATION; VALUE OF INFORMATION;

BAYES THEOREM; DECISION SUPPORT TECHNIQUES; INFORMATION SERVICES; RISK MANAGEMENT; UNITED STATES;

EID: 2442699044     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X04263157     Document Type: Review

References (66)

1. Commission on Risk Assessment and Risk Management. Framework for Environmental Health Risk Assessment. Washington (DC): Presidential/Congressional Commission on Risk Assessment and Risk Management; 1997.
2. National Research Council. Understanding Risk: Informing Decisions in a Democratic Society. Washington (DC): National Academy Press; 1996.
3. Raiffa H. Decision Analysis: Introductory Lectures on Choices under Uncertainty. New York: Random House; 1968.
4. Pratt JW, Raiffa H, Schlaifer RO. Introduction to Statistical Decision Theory. Cambridge (MA): MIT Press; 1995.
5. Raiffa H, Schlaifer RO. Applied Statistical Decision Theory. Cambridge (MA): Division of Research, Graduate School of Business Administration, Harvard University; 1961.
6. Howard RA. Information value theory. IEEE Trans Syst Sci Cybern. 1966;SSC2(1):22-6.
7. Howard RA. Value of information lotteries. IEEE Trans Syst Sci Cybern. 1967;SSC3(1):54-60.
8. Howard RA. The foundations of decision analysis. IEEE Trans Syst Sci Cybern. 1968;SSC-4(3):211-9.
9. Hazen GB, Sounderpandian J. Expected-utility preference reversals in information acquisition. J Risk Uncertain. 1999;18:125-36.
10. Brand KP, Small MJ. Updating uncertainty in an integrated risk assessment: conceptual framework and methods. Risk Anal. 1995;15:719-31.
11. Thompson KM, Graham JD. Going beyond the single number: using probabilistic risk assessment to improve risk management. Hum Ecol Risk Assess. 1996;2:1008-34.
12. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95-109.
13. Felli JC, Hazen GB. A Bayesian approach to sensitivity analysis. Health Econ. 1999;8:263-8.
14. Samson D, Wirth A, Rickard J. The value of information from multiple sources of uncertainty in decision-analysis. Eur J Oper Res. 1989;39:254-60.
15. Hammitt JK. Can more information increase uncertainty? Chance. 1995;8):15-7, 36.
16. Hammitt JK, Shlyakhter AI. The expected value of information and the probability of surprise. Risk Anal. 1999;19:135-52.
17. Hilton RW. The determinants of information value: synthesizing some general results. Manage Sci. 1981;27:57-64.
18. Thompson KM. Developing univariate distributions from data for risk analysis. Hum Ecol Risk Assess. 1999;5:755-83.
19. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical Decision Analysis. Philadelphia (PA): W. B. Saunders; 1980.
20. Phelps CE, Mushlin AI. Focusing technology-assessment using medical decision-theory. Med Decis Making, 1988;8:279-89.
21. Morgan MG, Henrion M. Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis. New York: Cambridge University Press; 1990.
22. Mooney C, Mushlin AI, Phelps CE. Targeting assessments of magnetic-resonance-imaging in suspected multiple-sclerosis. Med Decis Making. 1990;10:77-94.
23. Heckerman D, Horvitz E, Middleton B. An approximate nonmyopic computation for value of information. IEEE Transactions on Pattern Analysis and Machine Intelligence. 1993;15:292-8.
24. Mehrez A, Yuan Y, Gafni A. The search for information-a patient perspective on multiple opinions. Eur J Oper Res. 1995;85:244-62.
25. Owens DK, Nease RF. A normative analytic framework for development of practice guidelines for specific clinical populations. Med Decis Making. 1997;17:409-26.
26. Hunink MGM, Kuntz KM, Fleischmann KE, Brady TJ. Noninvasive imaging for the diagnosis of coronary artery disease: focusing the development of new diagnostic technology. Ann Intern Med. 1999;131:673-80.
27. Claxton K, Neumann PJ, Araki S, Weinstein MC. Bayesian value-of-information analysis-an application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care. 2001;17:38-55.
28. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis-implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. J Health Econ. 2001;20:109-29.
29. Thompson MS. Decision-analytic determination of study size. The case of electronic fetal monitoring. Med Decis Making. 1981;1:165-79.
30. Paltiel AD, Kaplan EH. The epidemiologic and economic consequences of aids clinical-trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1993;6:179-90.
31. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ. 1996;5:513-24.
32. Hornberger J. A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example. Am J Public Health. 1998;88:61-7.
33. Hornberger J, Eghtesady P. The cost-benefit of a randomized trial to a health care organization. Control Clin Trials. 1998;19:198-211.
34. Claxton K. Bayesian approaches to the value of information: implications for the regulation of new pharmaceutical. Health Econ. 1999;8:269-74.
35. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18:341-64.
36. Cher DJ, Maclure M. Use of randomized controlled trials in organizational decision making: a cost-minimization approach. Am J Manag Care. 2000;6:894-904.
37. Claxton K, Thompson KM. A dynamic programming approach to the efficient design of clinical trials. J Health Econ. 2001;20:797-822.
38. North DW, Merkhofer MW. A methodology for analyzing emission control strategies. Computers & Operations Research. 1976;3:185-207.
39. Finkel AM, Evans JS. Evaluating the benefits of uncertainty reduction in environmental-health risk management. JAPCA: The International Journal of Air Pollution Control and Hazardous Waste Management. 1987;37:1164-71.
40. Evans JS, Hawkins NC, Graham JD. The value of monitoring for radon in the home-a decision-analysis. JAPCA: The International Journal of Air Pollution Control and Hazardous Waste Management. 1988;38:1380-5.
41. Chao HP, Peck SC, Wan YS. Managing uncertainty-the tropospheric ozone challenge. Risk Anal. 1994;14:465-75.
42. Dakins ME, Toll JE, Small MJ. Risk-based environmental remediation-decision framework and role of uncertainty. Environ Toxicol Chem. 1994;13:1907-15.
43. Dakins ME, Toll JE, Small MJ, Brand KP. Risk-based environmental remediation: Bayesian Monte Carlo analysis and the expected value of sample information. Risk Anal. 1996;16:67-79.
44. Thompson KM, Evans JS. The value of improved national exposure information for perchloroethylene (Perc): a case study for dry cleaners. Risk Anal. 1997;17:253-71.
45. Lin CY, Gelman A, Price PN, Krantz DH. Analysis of local decisions using hierarchical modeling, applied to home radon measurement and remediation. Stat Sci. 1999;14:305-28.
46. Bartell SM, Ponce RA, Takaro TK, Zerbe RO, Omenn GS, Faustman EM. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention. Risk Anal. 2000;20:87-99.
47. Lave LB, Omenn GS. Cost-effectiveness of short-term tests for carcinogenicity. Nature. 1986;324:29-34.
48. Lave LB, Omenn GS. Screening toxic-chemicals-how accurate must tests be? J Am Coll Toxicol. 1988;7:565-74.
49. Lave LB, Ennever FK, Rosenkranz HS, Omenn GS. Information value of the rodent bioassay. Nature. 1988;336:631-3.
50. Olson LJ. The search for a safe environment-the economics of screening and regulating environmental hazards. J Environ Econ Manage. 1990;19:1-18.
51. Taylor AC, Evans JS, McKone TE. The value of animal test information in environmental-control decisions. Risk Anal. 1993;13:403-12.
52. Omenn GS, Stuebbe S, Lave LB. Predictions of rodent carcinogenicity testing results-interpretation in light of the Lave-Omenn value-of-information model. Mol Carcinog. 1995;14:37-45.
53. Massmann J, Freeze RA. Groundwater contamination from waste management sites-the interaction between risk-based engineering design and regulatory policy. 2. Results. Water Resour Res. 1987;23:368-80.
54. Reichard EG, Evans JS. Assessing the value of hydrogeologic information for risk-based remedial action decisions. Water Resour Res. 1989;25:1451-60.
55. Tucciarelli T, Pinder G. Optimal data acquisition strategy for the development of a transport model for groundwater remediation. Water Resour Res. 1991;27:577-88.
56. Freeze RA, James B, Massmann J, Sperling T, Smith L. Hydrogeological decision-analysis. 4. The concept of data worth and its use in the development of site investigation strategies. Ground Water. 1992;30:574-88.
57. Wagner JM, Shamir U, Nemati HR. Groundwater quality management under uncertainty-stochastic-programming approaches and the value of information. Water Resour Res. 1992;28:1233-46.
58. James BR, Freeze RA. The worth of data in predicting aquitard continuity in hydrogeological design. Water Resour Res. 1993;29:2049-65.
59. James BR, Gorelick SM. When enough is enough-the worth of monitoring data in aquifer remediation design. Water Resour Res. 1994;30:3499-513.
60. James BR, Gwo JP, Toran L. Risk-cost decision framework for aquifer remediation design. Journal of Water Resources Planning and Management-Asce. 1996;122:414-20.
61. Wagner BJ. Evaluating data worth for ground-water management under uncertainty. Journal of Water Resources Planning and Management-Asce. 1999;125:281-8.
62. Phelps CE, Mushlin AI. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int J Technol Assess Health Care. 1991;7:12-21.
63. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253-8.
64. Ades AE, Cliffe S. Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty. Med Decis Making. 2002;22:359-71.
65. Yokota F, Thompson KM. Value of information (VOI) analysis in environmental health risk management (EHRM) decisions. Risk Anal. Forthcoming.
66. Karnon J. Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysis. Health Policy. 2002;61:329-47.